Health

Which test should you go for? Can you even schedule one? How long should you isolate before your test, and afterward? There’s a lot to consider.

The gift we all want — an end to pandemic life — is likely several months away. The just-imposed shutdowns will be with us until New Year’s.

As COVID-19 hospitalizations surge, new data released by the federal government show how many hospitals are struggling with staffing.

Positive coronavirus cases in 22 of the state’s 24 correctional institutions are putting advocates, and families with loved ones on the inside, on edge.

Pennsylvania Secretary of Health Rachel Levine said the federal government will distribute the antibodies to healthcare systems in the state.

The earliest shipments are expected to go to health care professionals and first responders first, with the vaccine likely becoming available to the public in April or May.

Since Nov. 12, the city Medical Examiner's office has confirmed three overdose deaths among restaurant and bar workers who thought they were using cocaine.

There are still dozens of options available, although many have long wait times and longer turnaround.

The 30 beds at the first site sometimes fill up, officials said, with people from shelters or those experiencing homelessness.

The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 in a study.

COVID-19 has taken hundreds of thousands of lives in the U.S. already, some very quickly. There will be mourning, and remembering

This comes as coronavirus cases are spiking in Philadelphia, and across the state and country. It’s also not the first coronavirus incident Philly police have had.

Health Commissioner Dr. Thomas Farley warned of increasing coronavirus numbers across the board.

Advocates for the elderly say a tandem wave of death separate from the virus has claimed tens of thousands more due to the mistakes of overburdened health care workers.

Trump is doubling down on a novel, unproven injection device, providing more than half a billion dollars in financing for something that is still awaiting FDA approval.